#CellCarta
LightNews LightNews
jobboardsearch.com
📢 Cellcarta is #hiring a Manager, Quality Management System And Supplier Quality (remote)!

🌎 Worldwide

🔗 http://jbs.ink/scm1dMPTbVQH

#jobalert #jobsearch #remotejobs #remotejob #remotework #wfh #aws #design
📢 Cellcarta is hiring a Manager, Quality Management System And Supplier Quality (remote)!
September 13, 2026 at 11:03 PM
jobboardsearch.com
📢 Cellcarta is #hiring a Manager, Quality Management System And Supplier Quality (remote)!

🌎 Worldwide

🔗 http://jbs.ink/FJf9SI7qoDXA

#jobalert #jobsearch #remotejobs #remotejob #remotework #wfh #aws #design
📢 Cellcarta is hiring a Manager, Quality Management System And Supplier Quality (remote)!
September 13, 2026 at 10:59 PM
bloodpac.bsky.social
Please join us in welcoming @cellcarta.bsky.social as BLOODPAC’s newest member! CellCarta is a global CRO providing precision medicine testing services & biomarker solutions, with capabilities spanning immune monitoring, proteomics, genomics, digital pathology, & more. Learn more: cellcarta.com
August 18, 2026 at 5:16 PM
jobboardsearch.com
📢 Cellcarta is #hiring a Proposal Specialist - Hybrid (montreal Area)!

🌎

🔗 http://jbs.ink/uDd2GRVrKqOb

#jobalert #jobsearch #remotejobs #aws
📢 Cellcarta is hiring a Proposal Specialist - Hybrid (montreal Area)!
August 17, 2026 at 2:17 AM
bt-spatial.bsky.social
Meet the Expert, Patrick Reese, and learn how his team at @CellCarta leverages the COMET™ platform to drive operational excellence on a global scale.
Read his testimonial now: https://link.lunaphore.com/8vb
August 13, 2026 at 3:11 PM
newsen.bsky.social
CellCarta Strengthens Oncology Diagnostics with Tempus Partnership in CDx Lab Network#Canada#Montreal#CellCarta#Tempus_AI#Oncology_Diagnostics
CellCarta Strengthens Oncology Diagnostics with Tempus Partnership in CDx Lab Network
CellCarta enhances its CDx Commercialization Lab Network by partnering with Tempus AI, facilitating oncology diagnostic advancements and streamlining regulatory approvals.
third-news.com
August 6, 2026 at 1:53 PM
stocktitan.net
#TEM CellCarta Adds Tempus to CDx Commercialization Lab Network

https://www.stocktitan.net/news/TEM/cell-carta-adds-tempus-to-c-dx-commercialization-lab-ls5a9dcxw7t0.html
CellCarta Adds Tempus to CDx Commercialization Lab Network
MONTREAL, Aug. 6, 2026/ PRNewswire/-- CellCarta, a global CRO laboratory supporting the biopharmaceutical industry, today announced a strategic collaboration with Tempus AI, Inc.. Within the CellCarta network, the collaboration gives biopharma sponsors a more direct route from companion diagnostic development and regulatory approval to commercial use in...
www.stocktitan.net
August 6, 2026 at 1:15 PM
l2plabs.bsky.social
CellCarta Adds Tempus to CDx Commercialization Lab Network
Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta's CDx Accelerator Model. MONTREAL, Aug. 6, 2026 /PRNewswire/ -- CellCarta, a global CRO laboratory supporting the biopharmaceutical industry, today announced a strategic...
dlvr.it
August 6, 2026 at 1:17 PM
newsen.bsky.social
Revolune Launches New Service Provider Program for Enhanced Research Access#Germany#CellCarta#Oberkochen#Revolune#Concept_Life
Revolune Launches New Service Provider Program for Enhanced Research Access
Revolune has introduced a Service Provider Program that connects researchers with experienced service providers, enhancing access to multiplex immunofluorescence workflows.
third-news.com
August 4, 2026 at 12:27 PM
newsen.bsky.social
CellCarta Unveils New Consortium for Advancing Digital Pathology and AI in Drug Development#Canada#Montreal#Digital_Pathology#CellCarta#AI_Consortium
CellCarta Unveils New Consortium for Advancing Digital Pathology and AI in Drug Development
CellCarta launches a Global Digital Pathology and AI Consortium aiming to innovate biomarker discovery and precision diagnostics in drug development across various diseases.
third-news.com
July 15, 2026 at 1:05 PM
360dx.bsky.social
www.360dx.com/cancer/cellc...
CellCarta, Pillar Biosciences Partner to Offer NGS Tumor Profiling for Oncology Clinical Trials
The companies hope the partnership can streamline NGS tumor profiling and support scalable companion diagnostic programs for pharma and clinical customers.
www.360dx.com
April 2, 2026 at 1:45 PM
360dx.bsky.social
www.360dx.com/business-new...
Lunit, CellCarta Partner to Support AI-Enabled Digital Pathology CDx Development
Intended to assist biopharma developers of companion assays, the partnership follows one for clinical trial support the firms announced last year.
www.360dx.com
March 30, 2026 at 2:37 PM
360dx.bsky.social
www.360dx.com/cancer/cellc...
CellCarta Gains Exclusive Rights to Biofidelity's Aspire Lung Cancer Assay for Clinical Trials
The agreement follows a nonexclusive deal between the firms last year that allowed CellCarta to use the Aspyre Lung assay in clinical trials worldwide.
www.360dx.com
March 19, 2026 at 2:15 PM
360dx.bsky.social
www.360dx.com/business-new...
CellCarta, Biofidelity Partner to Offer Lung Cancer Assay for Clinical Trials
CellCarta will validate Biofidelity's Aspyre Lung assay in its European and US labs and will hold nonexclusive rights to use it in global clinical trials.
www.360dx.com
January 9, 2025 at 3:18 PM
watchmakergenomics.bsky.social
Join Watchmaker at #ESHG2026 for a 90-minute workshop with Dr. Laura Glaser (MGZ) & Dr. Pieter Mestdagh (CellCarta) on improving sequencing accuracy & scalability. We’ll also unveil Equinox Prime & EquiPlex Normalization. Visit us at Booth 256!

www.watchmakergenomics.com/events/eshg2...
June 3, 2026 at 4:55 PM
4040rec.bsky.social
#genomicsolutions #MolecularDiagnostics #Biofidelity #oncology #genomics4all #CellCarta #AspyreLung #precisionmedicine #nonsmallcelllungcancer #NSCLC #NSCLCbiomarkers #genomicservices #clinicaltrialenrolment #SimplifiedGenomicProfiling #SGP #qPCRplatforms
pharmatimes.com/news/biofide...
Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials - PharmaTimes
New partnership to advance precision medicine in lung cancer diagnosis
pharmatimes.com
January 20, 2025 at 3:20 PM
snoopiboard.bsky.social
HIRING: Data Analyst – Immunology
Remote: Full Remote Contract: Full time Salary: 15 - 15K yearly Experience: Mid-level (2-5 years) Work from: Canada Data Analyst - ImmunologyAre you looking for a career opportunity in the field of biotechnology? At CellCarta, our data ana...
jobs.snoopiboard.com.ng
January 16, 2025 at 4:04 AM
medcloudinsider.bsky.social
Lunit and CellCarta are teaming up to bring AI into digital pathology, improving biomarker discovery and precision oncology workflows.

Explore the partnership and what it means: https://medcloudinsider.com/blogs/medcloud-minute/2026/03/lunit-and-cellcarta-partner.aspx

#AI #Healthcare #Oncology
Lunit and CellCarta Partner to Advance AI in Digital Pathology -- MedCloudInsider
Collaboration focuses on supporting companion diagnostics through AI-driven analysis of pathology data.
medcloudinsider.com
April 1, 2026 at 2:10 PM
us-med.bsky.social
CellCarta Slashes Regulatory Bottlenecks Using Agentic AI | MISRYOUM
CellCarta has partnered with RegASK to automate its regulatory intelligence, saving nine hours of manual work weekly and accelerating drug development Stay updated with the latest global news from MISRYOUM.
misryoum.com
April 21, 2026 at 2:09 PM
newsen.bsky.social
Leica Biosystems and CellCarta Unveil Innovative Global CDx Development Framework#Canada#Montreal#Leica_Biosystems#CellCarta#CDx_Development
Leica Biosystems and CellCarta Unveil Innovative Global CDx Development Framework
Leica Biosystems and CellCarta introduce a pioneering framework for companion diagnostic development, optimizing global commercialization processes.
third-news.com
May 29, 2026 at 7:38 PM
newsen.bsky.social
Strategic Alliance Between CellCarta and Sonic Healthcare to Enhance Companion Diagnostics#USA#Montreal#CellCarta#SonicHealthcare#CompanionDiagnostics
Strategic Alliance Between CellCarta and Sonic Healthcare to Enhance Companion Diagnostics
CellCarta and Sonic Healthcare forge a partnership to streamline the commercialization of companion diagnostics through an innovative lab network.
third-news.com
May 27, 2026 at 3:29 PM
newsen.bsky.social
CellCarta and Pillar Biosciences Form a Strategic Alliance for Oncology Clinical Trials#Canada#Montreal#CellCarta#Pillar_Biosciences#Oncology_Trials
CellCarta and Pillar Biosciences Form a Strategic Alliance for Oncology Clinical Trials
CellCarta and Pillar Biosciences have partnered to enhance decentralized tumor profiling in oncology trials. This strategic move streamlines processes and supports rapid enrollment.
third-news.com
April 2, 2026 at 12:53 PM
newsen.bsky.social
Lunit and CellCarta Forge Alliance to Enhance AI-Driven Digital Pathology in Biopharma#South_Korea#Seoul#Lunit#CellCarta#AI_Pathology
Lunit and CellCarta Forge Alliance to Enhance AI-Driven Digital Pathology in Biopharma
Lunit and CellCarta have joined forces to accelerate AI-enabled digital pathology workflows, enhancing companion diagnostics in biopharma.
third-news.com
March 30, 2026 at 7:27 AM